Portfolio company
Fesarius Therapeutics
United States · £15.8m raised
Raised
£15.8m
Latest stage
Series A
Rounds recorded
1
Backed by
3 investors
Sectors
About
This company develops hydrogel dermal regeneration templates for surgeons and hospital systems to treat wounds and manage skin loss.
SourceFunding history · 1
Similar companies
TYBR Health
This company develops a hydrogel system for orthopaedic surgeons to protect tendons and ligaments from internal scarring following surgical procedures.
BioMimir
This company develops biomimetic polymers and resorbable wound fillers for healthcare providers to treat complex wounds and prevent scarring.
Kerecis
This company develops fish skin tissue regeneration products for medical professionals to treat patients with chronic wounds, burns and surgical complications.
GeniPhys
This company develops polymerisable collagen scaffolds for tissue restoration and wound management for medical patients and healthcare providers.
AddGraft Therapeutics
This company develops genetically engineered liquid skin grafts for patients with rare skin diseases and metabolic disorders.
Bioaesthetics
This company develops biologically derived collagen grafts to regenerate nipples and areolas for patients undergoing breast reconstruction surgery after mastectomies.
VERITACELL
This company produces surgical kits for point-of-care skin cell isolation and regeneration to help surgeons and hospitals treat patient wounds and scarring.
Besthealth4u
This company develops bio-based medical adhesives and wearable sensor patches for wound care and medical device manufacturers to prevent skin injuries and monitor healing.
